TP53 and neoplasm: The investigators explain that tumor cells acquire the ability to inhibit the canonical tumor-suppressive functions of p53 in normal fibroblasts, and in CAFs, the p53 activity becomes “rewired” to support their tumor-promoting functions (Arandkar et al. 2018).